TROW
27
-4
PEG
58
-6
NOC
51
-2
NUE
44
-7
PRU
54
-2
SEE
52
-3
AAPL
39
-3
EIX
45
-2
AES
39
2
COST
47
-9
TSCO
58
3
RHI
22
-5
EXC
66
2
CRM
35
3
SPG
48
-3
DD
32
-2
PM
81
2
RRC
65
2
WAT
59
-2
CA
18
-6
TROW
27
-4
PEG
58
-6
NOC
51
-2
NUE
44
-7
PRU
54
-2
SEE
52
-3
AAPL
39
-3
EIX
45
-2
AES
39
2
COST
47
-9
TSCO
58
3
RHI
22
-5
EXC
66
2
CRM
35
3
SPG
48
-3
DD
32
-2
PM
81
2
RRC
65
2
WAT
59
-2
CA
18
-6
Financhill
Back

Globant SA 10K Form

Sell
30

GLOB
Globant SA

Last Price:
$100.81
Seasonality Move:
14.31%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GLOB News And Ratings

See the #1 stock for the next 7 days that we like better than GLOB

GLOB Financial Statistics

Sales & Book Value

Annual Sales: $2.4B
Cash Flow: $-5.7M
Price / Cash Flow: 33.22
Annual Sales: $46.55
Price / Book: 2.14

Profitability

EPS (TTM): 3.38000
Net Income (TTM): $151.1M
Gross Margin: $863.4M
Return on Equity: 7.74%
Return on Assets: 5.17%

Globant SA Earnings Forecast

Key Globant SA Financial Ratios

  • The Gross Profit Margin over the past 22 years for GLOB is 35.74%.
  • The Selling, General & Administrative Expenses for GLOB have been equal to 19.89% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 17.29% of Operating Income.
  • The Net Earning history of GLOB is 6.86% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 14 years.

Globant SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: IT Services
Sector: Information Technology
Current Symbol: GLOB
CUSIP: L44385
Website: globant.com

Debt

Debt-to-Equity Ratio: 0.14
Current Ratio: 1.56
Quick Ratio: 1.49

Price-to-Earnings

Trailing P/E Ratio: 26.72
Forward P/E Ratio: 14.59

GLOB Technical Analysis vs Fundamental Analysis

Sell
30
Globant SA (GLOB) is a Sell

Is Globant SA a Buy or a Sell?

  • Globant SA stock is rated a Sell
    The current Globant SA [GLOB] share price is $99.39. The Score for GLOB is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.